Second Photo
fundable.
DATA PLATFORM
  • Dashboard
  • Companies
  • People
  • Investment Firms
  • Angels & Partners
COLLECTIONS
  • Lists
  • Saved Searches
  • Hiring Lists
WORKFLOWS
  • Deal Alerts
  • Integrations
  • API + Credits


logo
Antengene Corporation logo

Antengene Corporation

Recent Finacing

Series C

Recent Raise

$97M

Antengene is a Shanghai-based clinical-stage biopharmaceutical company that discovers, develops, manufactures and commercializes oncology and antiviral therapeutics, operating integrated R&D, clinical development and commercial teams across the Asia-Pacific.

Founded 2016
Shanghai, China
251-500
Publicly Traded
antengene.com

Highlights

Focus Areas

Biopharma
Biotechnology
Life Science
Pharmaceutical

Recent Investors

Qiming Venture Partners logo
Boyu Capital logo
Taikang logo
WuXi AppTec logo
TF Capital logo
FountainVest Partners logo
Celgene logo
GL Ventures logo
Fidelity Management & Research Company logo
GIC logo

Financials

$217M

Total Raised

2

Funding rounds

10

Investors


Team

Upgrade to view the team

See the team members at Antengene Corporation.